IL17A and psoriasis: IL-17 drives disease pathogenesis by activating psoriasis-related genes in keratinocytes via IL-22, IL-19, and IL-36 to increase epidermal hyperplasia and produce more antimicrobial peptides, including LL-37/cathelicidin [33].